SK

Sarepakkam Krithika Sakthi

Active Director Director DIN 09294451
DIN 09294451 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sarepakkam Krithika Sakthi

Data last updated:

Sarepakkam Krithika Sakthi is a Director at Skanda Hospital Private Limited (since 2021). The company operates in Healthcare.

DIN 09294451
Primary Designation Director
Industry Healthcare
First Appointment 26 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skanda Hospital Private Limited U85100AP2021PTC119228
Director26 Aug 20212021Active

Board colleagues of Sarepakkam Krithika Sakthi

NameDINCompanyDesignation
Singanamala Charan Vinith09294450Skanda Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Skanda Hospital Private Limited
Premium access

Shareholding and investment profile for Sarepakkam Krithika Sakthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarepakkam Krithika Sakthi

Sarepakkam Krithika Sakthi currently holds 1 directorship: Skanda Hospital Private Limited (Director, since 26 Aug 2021).

Sarepakkam Krithika Sakthi was first appointed on 26 Aug 2021 as Director at Skanda Hospital Private Limited.

The current boards of Sarepakkam Krithika Sakthi's companies include Singanamala Charan Vinith (Skanda Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available